Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Pariser

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
Journal of Drugs in Dermatology : JDD|January 18, 2017
Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Walter K Nahm, et al.
Cutis|October 8, 2005
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicleDavid M Pariser, Diane M Thiboutot, Scott D Clark, et al.
The Journal of Clinical and Aesthetic Dermatology|December 21, 2023
Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper ExtremitiesDaniel Piacquadio, Brian Berman, Daniel M Siegel, et al.
Dermatology and Therapy|November 21, 2024
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic DermatitisChien-Chia Chuang, David M Pariser, Eric Simpson, et al.
Journal of the American Academy of Dermatology|June 26, 2020
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 studyAditya K Gupta, Maria S Surprenant, Steven E Kempers, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% CreamNeal D Bhatia, David M Pariser, Leon Kircik, et al.
Journal of the American Academy of Dermatology|March 30, 2016
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasisRobert Bissonnette, David M Pariser, Norman R Wasel, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal HyperhidrosisDavid M Pariser, Janakan Krishnaraja, Thomas M Tremblay, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patientsAmy K Schecter, David M Pariser, Robert J Pariser, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque PsoriasisJeffrey L Sugarman, Linda Stein Gold, Mark G Lebwohl, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
Journal of Drugs in Dermatology : JDD|January 18, 2017
Results of a Phase 2, Randomized,Vehicle-Controlled Study Evaluating the Efficacy,Tolerability, and Safety of Daily or Twice Daily SB204 for the Treatment of Acne VulgarisLawrence F Eichenfield, Linda Stein Gold, Walter K Nahm, et al.
Cutis|October 8, 2005
The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicleDavid M Pariser, Diane M Thiboutot, Scott D Clark, et al.
The Journal of Clinical and Aesthetic Dermatology|December 21, 2023
Treatment Satisfaction and Acceptability of 20% Aminolevulinic Acid Photodynamic Therapy for the Treatment of Actinic Keratoses of the Face, Scalp, and Upper ExtremitiesDaniel Piacquadio, Brian Berman, Daniel M Siegel, et al.
Dermatology and Therapy|November 21, 2024
The Atopic Dermatitis Control Tool: Adaptation and Content Validation for Children and Caregivers of Children with Atopic DermatitisChien-Chia Chuang, David M Pariser, Eric Simpson, et al.
Journal of the American Academy of Dermatology|June 26, 2020
Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 studyAditya K Gupta, Maria S Surprenant, Steven E Kempers, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% CreamNeal D Bhatia, David M Pariser, Leon Kircik, et al.
Journal of the American Academy of Dermatology|March 30, 2016
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasisRobert Bissonnette, David M Pariser, Norman R Wasel, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Randomized, Placebo- and Active-Controlled Crossover Study of the Safety and Efficacy of THVD-102, a Fixed-dose Combination of Oxybutynin and Pilocarpine, in Subjects With Primary Focal HyperhidrosisDavid M Pariser, Janakan Krishnaraja, Thomas M Tremblay, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patientsAmy K Schecter, David M Pariser, Robert J Pariser, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque PsoriasisJeffrey L Sugarman, Linda Stein Gold, Mark G Lebwohl, et al.
Pageof 12